StockFin.ai
NewsScreensInsightsPricing
/
Sign inTry Free
SF
New ChatNewsInsightsScreenerPricing
Sign In
NewsScreensChatSign In

Tools

Search Companies
News & Filings
Insights & Articles
FeaturesComing Soon
Pricing
Home › News › PPLPHARMA › Announcement

Piramal Pharma Ltd (PPLPHARMA) — Announcement | 14 September 2026

14 September 2026 · BSE 🔴 High Importance Neutral
By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings
📢 Key Event
FDA issues Form 483 with 7 observations following UK facility inspection

Piramal Pharma disclosed that the US FDA conducted a GMP inspection at its Morpeth, UK facility from September 3-11, 2026, issuing Form 483 with 7 observations requiring corrective actions. The company confirmed it is addressing the observations and will submit a detailed response within the regulatory timeline, reaffirming its commitment to compliance standards.

📄 View Original Announcement (PDF)

📊 Stock Analysis — PPLPHARMA✨ Ask AI About This

About Piramal Pharma Ltd (PPLPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹27,485.68 CrROE: -3.8%ROCE: 1.7%

View full PPLPHARMA stock details →

📡 Get AI alerts when PPLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PPLPHARMA — Free

💡 Ask AI about this filing

"How will the FDA observations impact Piramal's US market approvals?""What is the expected timeline for resolving the 7 Form 483 observations?""How does this inspection affect Piramal's relationship with key US pharma clients?"
Ask AI Free →

📊 More PPLPHARMA filings

  • Announcement — 29 September 2026Piramal Pharma announced that its trading window will close on October 1, 2026, and remain shut for ...
  • 🔴 Corporate Action — 29 September 2026Piramal Pharma disclosed a GST audit order requiring Rs. 4,06,03,220 in input tax credit demand and ...
  • 🔴 Announcement — 18 September 2026Piramal Pharma disclosed that an independent ESG rating agency, Niche99, assigned it an ESG score of...
  • 🔴 Announcement — 8 September 2026Piramal Pharma announced its schedule for upcoming institutional investor meetings in late September...
  • 🔴 Announcement — 3 September 2026Piramal Pharma disclosed that NSE Sustainability Ratings and Analytics assigned an ESG rating of 65 ...
See all PPLPHARMA filings →

🔥 Also filed on 14 September 2026

HYUNDAIHyundai Motor India LtdAnnouncement544251Share Samadhan LtdCorporate Action544844Poojaa Precision Engg. LtdAnnouncementSATINSatin Creditcare Network LtdAnnouncementKECKEC International LtdAnnouncementCOFORGECoforge LtdAnnouncement
View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PPLPHARMA files new disclosures

Track PPLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track PPLPHARMA — Free

Free account · 2 AI queries/day

© 2026 StockFin.ai is not a SEBI-registered advisor. For informational purposes only.

Data provided by CMOTS Internet Technologies Pvt Ltd

AboutPrivacy PolicyTerms of ServicePricing

Latest News

View all →
Hitech Corporation Ltd

Hitech Corporation Limited received a Letter of Offer for voluntary delisting of its equity shares from BSE and NSE.

29 SeptHITECHCORP
Read more →
Enbee Trade & Finance Ltd

Promoter member sells shares

29 Sept512441
Read more →
KSB Ltd

KSB receives award order from Dangote Projects Free Zone Enterprise

29 SeptKSB
Read more →
Niyogin Fintech Ltd

Court‑convened meeting of creditors and shareholders scheduled for October 30, 2026.

29 Sept538772
Read more →
Niyogin Fintech Ltd

Court‑convened meeting scheduled for scheme approval

29 Sept538772
Read more →
Niyogin Fintech Ltd

Court-convened meeting scheduled for scheme approval

29 Sept538772
Read more →
Ansal Properties & Infrastructure Ltd

Board approved audited standalone financial results and no dividend for FY2026.

29 SeptANSALAPI
Read more →
Ansal Properties & Infrastructure Ltd

Board approved standalone audited financial results for FY2026 and appointed J.D. Associates as cost auditors.

29 SeptANSALAPI
Read more →
Ganesh Benzoplast Ltd

Ganesh Benzoplast signs definitive agreements to sell its liquid storage tank and railway network businesses to Cisternina Logistics

29 SeptGANESHBE
Read more →
JSW Energy Ltd

India Ratings assigns IND AA-/Stable/IND A1+ rating to Maruti Clean Coal & Power Limited's bank loan facilities

29 SeptJSWENERGY
Read more →
JSW Energy Ltd

JSW Thermal Energy assigned IND A+ stable rating by India Ratings

29 SeptJSWENERGY
Read more →
Cummins India Ltd

Announcement Under Regulation 30 Of SEBI (LODR) Regulations.

29 SeptCUMMINSIND
Read more →
ESDS Software Solution Ltd

Q1 FY27 revenue up 7.28% YoY to INR 133.66 crores, PAT up 14% to INR 29.28 crores

29 SeptESDS
Read more →
Artemis Medicare Services Ltd

Company receives GST show cause notice over in-patient medicine pricing

29 SeptARTEMISMED
Read more →
Samvardhana Motherson International Ltd

Rating outlook upgraded from Stable to Positive

29 SeptMOTHERSON
Read more →
Muthoot Capital Services Ltd

Announcement under Regulation 30 (LODR)-Credit Rating

29 SeptMUTHOOTCAP
Read more →
JSW Cement Ltd

Board approves scheme of arrangement for Shiva Cement amalgamation with JSW Cement.

29 SeptJSWCEMENT
Read more →
Mindspace Business Parks REIT

Insider relative purchased 5,982 REIT units

29 SeptMINDSPACE
Read more →
Race Eco Chain Ltd

Rights issue approved for subsidiary Ganesha Recycling Chain

29 SeptRACE
Read more →
Saurashtra Cement Ltd

Mehta Family Trust increased indirect stake in Saurashtra Cement via Omna Enterprises LLP acquisition.

29 SeptSAURASHCEM
Read more →